Jeito Capital co-leads EUR 80 million Series B financing in European oncology company, Precirix
Jeito Capital co-leads EUR 80 million Series B financing in European oncology company, Precirix Jeito Capital chooses Precirix, a clinical-stage biotechnology company developing precision radiopharmaceuticals